Primary Cells Market Overview

The global primary cells market has been segmented on the basis of the end user, origin, type, and lastly region. Based on end users, this market has been segmented into research institutes and life science research companies. On the basis of origin, the market has been segmented into gastrointestinal cells, hematopoietic cells, heart cells, liver cells, lung cells, renal cells, skeletal and muscle cells, skin cells, and others. By type, the market has been segmented into animal; primary and human primary cells. Animal primary cells are isolated and purified from qualified laboratory animal tissues. Primary human cells are directly cultured from their source organ tissue or blood cells.The primary cells market is projected to reach USD 1,085.82 Million by 2030 at 10.40% CAGR during the forecast period 2022-2030.

In addition, the increasing preference for primary cells to develop new drugs can strengthen the Primary Cells Market considerably during the assessment period.Increased research activities focused on biopharmaceutical discovery and biotechnology, increased investment in cancer research, growing demand for monoclonal antibodies and higher healthcare expenditure are some of the key factor influencing the global primary cells market. Primary human cells are preferred over cell lines which also remains a positive factor. Unlike endothelial cell lines, endothelial cells retain most functional markers. Primary cells being a novel technology is relatively more expensive. At the same time, issue of cell contamination is yet to be effectively addressed.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6296

Primary Cells Market Segmentation

MRFR’s report includes an in-depth segmental analysis of the global primary cell market based on type, origin and end user.

Based on type, the market has been segmented into animal primary cells and human primary cells. Based on origin, the market has been segmented into hematopoietic cells, liver cells, renal cells, skeletal and muscle cells, skin cells, gastrointestinal cells, lung cells, heart and others. Based on end-user, the market has been segmented into life science research companies and research institutes.

Key Players

Renowned players of the global primary cells market are Thermo Fisher Scientific Inc. (US), American Type Culture Collection (ATCC) ( Virginia), AllCells (US), Axol Bioscience Ltd (UK), Lonza Group, AG (Switzerland), Cell Biologics, Inc. (Chicago), Merck KGaA (Germany), STEMCELL Technologies Inc. (Canada), PromoCell (UK), ZenBio, Inc. (Research Triangle Park, NC), and among others.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/primary-cells-market-6296

  • Primary Cells Market Regional Analysis

    Based on the region, the global primary cells market covers the recent trends and growth opportunities across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will command the largest share in the market over the forecast period. Factors fuelling the market growth include increasing government funding and research, technological advancements, and growing prevalence of cancer. Besides, a huge patient pool suffering from cancer and rising healthcare expenditure by government organizations to offer a better life to people is also adding market growth. 

    The global primary cells market in Europe is predicted to hold the second-largest share over the forecast period. Factors propelling the market growth include the presence of developed economies such as France, the UK, and Germany, increasing cases of lifestyle-associated conditions, and favorable government laws and initiatives. Besides, increased investments in R&D activities are also adding market growth. 

    The global primary cells market in the APAC region is predicted to grow at a quick pace during the forecast period. The developing healthcare sector in Australia, India, Japan, and China, growing geriatric population, and rising per capita health spending are adding market growth. 

    The global primary cells market in the MEA is predicted to have the smallest share over the forecast period for the limited access to treatment facilities. Meanwhile, increasing expenditure by healthcare companies in Saudi Arabia coupled with new product launches, are likely to boost the market growth. 

     

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com